Please click here to download the Course Flyer
Primary care practitioners can play a crucial role in vastly improving the health outcomes of their Italian-speaking patients through early diagnosis and appropriate management of hepatitis B. Liver cancer, a large proportion of which is attributable to hepatitis B, is the fastest increasing cause of cancer death in Australia. Studies have shown that antiviral therapy for CHB can reduce the risk of liver cancer by 50% in only a few years.
• Know who to test and how to confidently interpret test results.
• Improve the outcome of patients by early diagnosis, follow up and appropriate management (including vaccination).
• Describe the intervention points throughout the natural history of HBV.
• Identify treatment options and the need for lifelong monitoring for people living with chronic hepatitis B.
Conditions of Registration:
Registration cancellations and amendments must be notified in writing to ASHM. Cancellations received before 2 May 2017 will not incur a cancellation fee. Cancellations received in writing after 2 May 2017 will incur a $70 per day cancellation fee. This fee may be waived in exceptional circumstances at the discretion of ASHM.
As an alternative to cancellation, your registration may be transferred to another person without incurring any penalty. ASHM must be advised of the transfer in writing. Please email the name, position, phone and email address of the new delegate to email@example.com.